In vivo evidence for the critical importance of LPA2 in colon cancer has been demonstrated in the rodent models of ApcMin/+ and colitis-induced colon cancer, where loss of LPA2 reduces tumor burden [24, 25]. This evidence concerns the gene LPAR2 and colonic neoplasm.